For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

IMPORTANT: In order to be considered for this position, a resume/CV must be uploaded and submitted during the application process. Please make sure work history and education are added correctly.

Job Summary

We have two exciting opportunities for motivated, driven and enthusiastic Veterinary Pathologists in our Pathology Department at Charles River, Tranent.

You will be joining a globally recognised company who are continually growing and have recently gone through an unprecedented period of growth.

The CRL Edinburgh Department of Pathology provides support to the business by generating and interpreting pathology data from GLP, GMP, Target Animal Safety and Discovery studies in a variety of test species. Globally, CRL employs over 130 pathologists of which the Edinburgh pathology team currently comprises 11 team members. At CRL Edinburgh we work on a wide variety of test items including small molecule, large molecule, gene and stem cell therapies as well as medical devices. In determining the safety or efficacy of a test item we employ a variety of animal and in-vitro model systems and techniques such as bright field microscopic analysis, IHC/ISH target detection, microautoradiography, digital pathology and machine/ deep learning based image analysis.

What will you have?

• A veterinary degree (DVM, BVM&S, BVMS, BVetMed, VetMB or BVSc)
• Pathology boards (FRCPath, DipIECVP, DipJSTP DipJCVP or DACVP)
• Histopathology and Necropsy experience within Pharmaceutical or Agrochemical industry
• Postgraduate qualification in veterinary pathology (MSc or PhD)
• Full training in GLP

The salary will depend on skills and experience.



IMPORTANT: A resume is required to be considered for this position. If you have not uploaded your resume in your candidate profile, please return to upload field and attach your resume/CV.

About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.

About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.

For more information, please visit www.criver.com.